Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

April Armstrong

Showing results (91-100 of 124) with videos related to

Pageof 13
Sort By:
Dermatology and Therapy|September 19, 2025
Optimal Itch Response in Adults Treated with Dupilumab for Moderate-to-Severe Atopic DermatitisSonja Ständer, Gil Yosipovitch, Brian S Kim, et al.
JAMA Dermatology|February 18, 2026
Three-Year Patient-Reported Outcomes From Bimekizumab for Plaque Psoriasis: The BE RADIANT Randomized Clinical Trial With Open-Label ExtensionMatthias Augustin, Steven R Feldman, Richard B Warren, et al.
Dermatology and Therapy|May 11, 2022
Real-World Effectiveness of Dupilumab in Atopic Dermatitis Patients: Analysis of an Electronic Medical Records DatasetLawrence F Eichenfield, April Armstrong, Emma Guttman-Yassky, et al.
ERJ Open Research|July 19, 2023
A Phase 2 randomised study to establish efficacy, safety and dosing of a novel oral cathepsin C inhibitor, BI 1291583, in adults with bronchiectasis: AirleafJames D Chalmers, Abhya Gupta, Sanjay H Chotirmall, et al.
The New England Journal of Medicine|April 23, 2021
Bimekizumab versus Adalimumab in Plaque PsoriasisRichard B Warren, Andrew Blauvelt, Jerry Bagel, et al.
Dermatology and Therapy|October 29, 2021
Dupilumab Treatment Provides Sustained Improvements Over 2 Years in Symptoms and Quality of Life in Adults with Atopic DermatitisGil Yosipovitch, Marjolein de Bruin-Weller, April Armstrong, et al.
Journal of the American Academy of Dermatology|September 22, 2023
Development of the Generalized Pustular Psoriasis Clinical Assessment ToolAmit Garg, Megan H Noe, Milan J Anadkat, et al.
Dermatology and Therapy|December 13, 2021
Continued Treatment with Dupilumab is Associated with Improved Efficacy in Adults with Moderate-to-Severe Atopic Dermatitis Not Achieving Optimal Responses with Short-Term TreatmentApril Armstrong, Andrew Blauvelt, Eric L Simpson, et al.
Journal of the American Academy of Dermatology|December 21, 2024
The association between obesity and efficacy of psoriasis therapies: An expert consensus panelJoshua Burshtein, April Armstrong, May Chow, et al.
JAMA Dermatology|January 11, 2023
Efficacy and Safety of Lebrikizumab in Combination With Topical Corticosteroids in Adolescents and Adults With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical Trial (ADhere)Eric L Simpson, Melinda Gooderham, Andreas Wollenberg, et al.
Pageof 13

Showing results (91-100 of 124) with videos related to

Sort By:
Pageof 13
Dermatology and Therapy|September 19, 2025
Optimal Itch Response in Adults Treated with Dupilumab for Moderate-to-Severe Atopic DermatitisSonja Ständer, Gil Yosipovitch, Brian S Kim, et al.
JAMA Dermatology|February 18, 2026
Three-Year Patient-Reported Outcomes From Bimekizumab for Plaque Psoriasis: The BE RADIANT Randomized Clinical Trial With Open-Label ExtensionMatthias Augustin, Steven R Feldman, Richard B Warren, et al.
Dermatology and Therapy|May 11, 2022
Real-World Effectiveness of Dupilumab in Atopic Dermatitis Patients: Analysis of an Electronic Medical Records DatasetLawrence F Eichenfield, April Armstrong, Emma Guttman-Yassky, et al.
ERJ Open Research|July 19, 2023
A Phase 2 randomised study to establish efficacy, safety and dosing of a novel oral cathepsin C inhibitor, BI 1291583, in adults with bronchiectasis: AirleafJames D Chalmers, Abhya Gupta, Sanjay H Chotirmall, et al.
The New England Journal of Medicine|April 23, 2021
Bimekizumab versus Adalimumab in Plaque PsoriasisRichard B Warren, Andrew Blauvelt, Jerry Bagel, et al.
Dermatology and Therapy|October 29, 2021
Dupilumab Treatment Provides Sustained Improvements Over 2 Years in Symptoms and Quality of Life in Adults with Atopic DermatitisGil Yosipovitch, Marjolein de Bruin-Weller, April Armstrong, et al.
Journal of the American Academy of Dermatology|September 22, 2023
Development of the Generalized Pustular Psoriasis Clinical Assessment ToolAmit Garg, Megan H Noe, Milan J Anadkat, et al.
Dermatology and Therapy|December 13, 2021
Continued Treatment with Dupilumab is Associated with Improved Efficacy in Adults with Moderate-to-Severe Atopic Dermatitis Not Achieving Optimal Responses with Short-Term TreatmentApril Armstrong, Andrew Blauvelt, Eric L Simpson, et al.
Journal of the American Academy of Dermatology|December 21, 2024
The association between obesity and efficacy of psoriasis therapies: An expert consensus panelJoshua Burshtein, April Armstrong, May Chow, et al.
JAMA Dermatology|January 11, 2023
Efficacy and Safety of Lebrikizumab in Combination With Topical Corticosteroids in Adolescents and Adults With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical Trial (ADhere)Eric L Simpson, Melinda Gooderham, Andreas Wollenberg, et al.
Pageof 13